Thus, transgenic mice overexpressing APP or PSENs with fAD mutations have been widely utilized in AD research, given that they nicely recapitulate most AD-related pathologies including Aβ plaque formation and cognitive impairment [43,44]. The gene discussed is APP; the disease is Alzheimer disease.